Antibody shows early promise in AML/MDS trialSeptember 20, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
CHMP recommends approval of generic imatinibSeptember 18, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
VSTs can treat 5 different viral infections after HSCTAugust 14, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Predicting response to treatment in AML, MDSJuly 26, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Company discontinues phase 3 trial of vadastuximab talirine in AMLJune 20, 2017Leukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Azacitidine alone comparable to AZA combos for most MDS patientsJune 5, 2017AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Authority on hematologic malignancies diesMay 31, 2017AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic SyndromeCML
Drug elicits responses in MDS patientsMay 10, 2017AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Novel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
Study shows similar outcomes with RIC and MAC in MDSMay 5, 2017AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationMyelodysplastic Syndrome
Role of TET2 in hematologic malignanciesApril 26, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Protein may prevent transformation from MDS to AMLMarch 28, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
FDA grants mAb orphan designation for MDSMarch 12, 2017AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
